Fevertree Drinks (GB:FEVR)

Fevertree Drinks (FEVR) Stock Price & Analysis


FEVR Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range792.63p - 1,629.59p
Previous Close1,445p
Average Volume (3M)517.04K
Market Cap
Enterprise Value160.59B
Total Cash (Recent Filing)£95.30M
Total Debt (Recent Filing)£16.90M
Price to Earnings (P/E)67.6
Sep 12, 2023
0.14 (0.01%)
Share Statistics
EPS (TTM)0.21
Shares Outstanding116,563,677
10 Day Avg. Volume344,630
30 Day Avg. Volume517,036
Standard Deviation0.13
Financial Highlights & Ratios
Price to Book (P/B)891.67
Price to Sales (P/S)662.11
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside-8.13% Downside
Rating ConsensusHold
Number of Analyst Covering8




What was Fevertree Drinks’s price range in the past 12 months?
Fevertree Drinks lowest stock price was 792.63p and its highest was 1629.59p in the past 12 months.
    What is Fevertree Drinks’s market cap?
    Currently, no data Available
    When is Fevertree Drinks’s upcoming earnings report date?
    Fevertree Drinks’s upcoming earnings report date is Sep 12, 2023 which is in 106 days.
      How were Fevertree Drinks’s earnings last quarter?
      Fevertree Drinks released its earnings results on Mar 22, 2023. The company reported 0.093p earnings per share for the quarter, missing the consensus estimate of 0.096p by -0.003p.
        Is Fevertree Drinks overvalued?
        According to Wall Street analysts Fevertree Drinks’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Fevertree Drinks pay dividends?
          Fevertree Drinks pays a Annually dividend of 10.68p which represents an annual dividend yield of 1.12%. See more information on Fevertree Drinks dividends here
            What is Fevertree Drinks’s EPS estimate?
            Fevertree Drinks’s EPS estimate is £0.09.
              How many shares outstanding does Fevertree Drinks have?
              Fevertree Drinks has 116,563,800 shares outstanding.
                What happened to Fevertree Drinks’s price movement after its last earnings report?
                Fevertree Drinks reported an EPS of 0.093p in its last earnings report, missing expectations of 0.096p. Following the earnings report the stock price went up 9.462%.
                  Which hedge fund is a major shareholder of Fevertree Drinks?
                  Currently, no hedge funds are holding shares in GB:FEVR


                  Fevertree Drinks Stock Smart Score

                  The Fevertree Drinks Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Fevertree Drinks

                  Fevertree Drinks Plc manufactures and supplies premium carbonated mixes. It sells carbonated mixers to hotels, restaurants, bars and cafes as well as supermarkets and off-licenses for retail purchase. The company was founded by Charles Timothy Rolls and Timothy Daniel Gray Warrillow in 2004 and is headquartered in London, The United Kingdom.


                  Top 5 ETFs holding FEVR

                  Market Value
                  Smart Score
                  dbxt FTSE ALL-S Shs -1D- Distribution
                  Lyxor Core UK Equity All Cap (DR) UCITS ETF
                  Up to five ETFs with an Outperform Smart Score that hold FEVR. The ETFs are listed according to market value of FEVR within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Coca-Cola Europacific Partners
                  AG Barr

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis